LISINOPRIL CLEARS FDA AFTER 20-MONTH REVIEW; MERCK SECOND-GENERATION ACE PRODUCT WILL BE COMARKETED BY STUART; FIRMS HEAVILY PROMOTING BRANDS TO MDs